Results 201 to 210 of about 44,008 (229)

Pathophysiology of Diabetic Macular Edema

2007
Diabetic maculopathy is the leading cause of visual loss in diabetic patients. The pathogenesis is not fully understood and a satisfactory therapy is currently not available. Malfunction of the blood-retinal barrier plays a central role in the disease and leads to retinal edema and secondary photoreceptor dysfunction.
Antonia M, Joussen, Neil, Smyth, Carien, Niessen   +2 more
openaire   +2 more sources

Photocoagulation for Diabetic Macular Edema

Archives of Ophthalmology, 1986
To the Editor. —The Early Treatment Diabetic Retinopathy Study Research Group (ETDRS) should be complimented for their efforts in carrying out the randomized clinical trial designed to evaluate photocoagulation and aspirin treatment in the management of patients with nonproliferative diabetic retinopathy.
openaire   +2 more sources

Vitrectomy for Diabetic Cystoid Macular Edema

Japanese Journal of Ophthalmology, 2001
We evaluated the visual outcome of vitrectomy for diabetic cystoid macular edema.Visual outcome and factors which may influence final visual acuity were assessed and documented retrospectively in 45 eyes of 40 patients, all of whom were followed for at least 6 months postoperatively.Final postoperative visual acuity was two or more lines better than ...
Yukihiro, Sato, Zeon, Lee, Hiroyuki, Shimada   +2 more
openaire   +3 more sources

Diabetic Macular Edema

2002
Diabetic retinopathy remains one of the four major causes of blindness in the western world [1], [2]. Blindness from diabetic retinopathy results from consequences of proliferative diabetic retinopathy and from diabetic macular edema. Proliferative diabetic retinopathy is more likely than macular edema to cause rapid and severe loss of vision.
openaire   +1 more source

Pathophysiology of Diabetic Macular Edema

International Ophthalmology Clinics, 2009
Ajay, Singh, Jay M, Stewart
openaire   +2 more sources

Ranibizumab for Diabetic Macular Edema

Ophthalmology, 2013
Rahul, Mayor, Manisha, Agarwal, Shalini, Singh, Ramesh, Venkatesh   +3 more
openaire   +2 more sources

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

Ophthalmology, 2020
Kristin Josic, Carl Baker, Wesley T Beaulieu   +2 more
exaly  

The Broader Economic Value of Treatment for Diabetic Macular Edema

Diabetes Care, 2023
Karen Mulligan, Bryan Tysinger, Philip J Ferrone   +2 more
exaly  

Current Treatments for Diabetic Macular Edema

International Journal of Molecular Sciences, 2023
Tomoaki Tatsumi
exaly  

Diabetic Macular Edema: Pathogenesis and Treatment

Survey of Ophthalmology, 2009
Neelakshi Bhagat, Marco A Zarbin
exaly